These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17684474)

  • 1. Pharmacogenetic studies in depression: a proposal for methodologic guidelines.
    Serretti A; Kato M; Kennedy JL
    Pharmacogenomics J; 2008 Apr; 8(2):90-100. PubMed ID: 17684474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not as golden as standards should be: interpretation of the Hamilton Rating Scale for Depression.
    Kriston L; von Wolff A
    J Affect Disord; 2011 Jan; 128(1-2):175-7. PubMed ID: 20696481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study designs and outcomes in antidepressant clinical trials.
    Khan A; Schwartz K
    Essent Psychopharmacol; 2005; 6(4):221-6. PubMed ID: 16041918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome criteria in antidepressant drug trials: self-rating versus observer-rating scales.
    Möller HJ
    Pharmacopsychiatry; 1991 May; 24(3):71-5. PubMed ID: 1891483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression and randomized, controlled trials: problems and solutions.
    Hatcher S
    Expert Rev Neurother; 2006 Jan; 6(1):41-6. PubMed ID: 16466310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales.
    Laenen A; Alonso A; Molenberghs G; Vangeneugden T; Mallinckrodt CH
    J Psychiatr Res; 2009 Apr; 43(7):730-8. PubMed ID: 18986657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HTTLPR rs25531A > G differentially influence paroxetine and fluvoxamine antidepressant efficacy: a randomized, controlled trial.
    Kato M; Nonen S; Serretti A; Tetsuo S; Takekita Y; Azuma J; Kinoshita T
    J Clin Psychopharmacol; 2013 Feb; 33(1):131-2. PubMed ID: 23288236
    [No Abstract]   [Full Text] [Related]  

  • 10. [Status of and perspectives on psychiatric genomic medicine].
    Mors NP; Børglum AD
    Ugeskr Laeger; 2005 May; 167(20):2191-3. PubMed ID: 15987082
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenetic considerations for late life depression therapy.
    Pitychoutis PM; Kokras N; Sanoudou D; Dalla C; Papadopoulou-Daifoti Z
    Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):989-99. PubMed ID: 23641676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drug targets in the signaling pathways activated by antidepressants.
    Páez-Pereda M
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1010-6. PubMed ID: 15946780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics and bipolar disorder.
    Mamdani F; Groisman IJ; Alda M; Turecki G
    Pharmacogenomics J; 2004; 4(3):161-70. PubMed ID: 15079146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methodologic problems of clinical investigations of antidepressants].
    Puzyński S
    Psychiatr Pol; 2005; 39(3):435-47. PubMed ID: 16149754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on the design and reporting of studies on drug-gene interaction.
    Smits KM; Schouten JS; Smits LJ; Stelma FF; Nelemans P; Prins MH
    J Clin Epidemiol; 2005 Jul; 58(7):651-4. PubMed ID: 15939214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressed mood during pregnancy and after childbirth. Treatment for depression is important confounding variable.
    Sheehan J; Crotty FM
    BMJ; 2001 Dec; 323(7325):1367; author reply 1368. PubMed ID: 11791255
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
    Hennings JM; Owashi T; Binder EB; Horstmann S; Menke A; Kloiber S; Dose T; Wollweber B; Spieler D; Messer T; Lutz R; Künzel H; Bierner T; Pollmächer T; Pfister H; Nickel T; Sonntag A; Uhr M; Ising M; Holsboer F; Lucae S
    J Psychiatr Res; 2009 Jan; 43(3):215-29. PubMed ID: 18586274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based guidelines for interpretation of the Hamilton Rating Scale for Depression.
    Furukawa TA; Akechi T; Azuma H; Okuyama T; Higuchi T
    J Clin Psychopharmacol; 2007 Oct; 27(5):531-4. PubMed ID: 17873700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.